In a target trial emulation using pooled ACCORD-BP and SPRINT data (5779 participants; 2754 matched), CCB-based regimens were associated with lower visit-to-visit systolic BP variability than RAS inhibitor- or diuretic-based regimens, with no significant MACE differences.
RCTn = 5,779
Qiao et al. Blood Pressure Variability and Outcomes Across Antihypertensive Regimens